Authors: | Arlin, Z. A.; Berman, E.; Jhanwar, S.; Gams, R.; Schoch, I.; Dukart, G. |
Article Title: | Treatment of blastic transformation of chronic myelogenous leukemia with mitoxantrone |
Abstract: | Twenty-four patients with blastic-phase chronic myelogenous leukemia (CML) were treated with mitoxantrone. The patients included 19 whose cells were Philadelphia chromosome (Ph1+) and 5 who were either Ph1- or in whom cytogenetics were not available. Six of the 19 whose cells were Ph1+ responded and one of those who were Ph1- responded. The patients were further characterized into lymphoid or nonlymphoid on the basis of terminal deoxynucleotidyl transferase or morphology. Two of the patients with lymphoid transformation and 3 of those with nonlymphoid transformation responded. In 3 patients post-treatment cytogenetic evaluation revealed the presence of Ph1- metaphases. We conclude that mitoxantrone has modest activity in blCML and that the cytogenetic responses suggest the possibility of greater efficacy in chronic-phase CML. © 1986 Springer-Verlag. |
Keywords: | adult; cancer chemotherapy; clinical article; aged; middle aged; drug efficacy; chemotherapy; heredity; cytogenetics; chronic myeloid leukemia; histology; drug mechanism; bone marrow biopsy; diagnosis; mitoxantrone; drug therapy; dna nucleotidylexotransferase; therapy; intravenous drug administration; philadelphia 1 chromosome; blast cell; philadelphia chromosome; anthraquinones; leukemia, myelocytic, acute; humans; human; male; female; priority journal; blast transformation; blood and hemopoietic system |
Journal Title: | Cancer Chemotherapy and Pharmacology |
Volume: | 17 |
Issue: | 2 |
ISSN: | 0344-5704 |
Publisher: | Springer |
Date Published: | 1986-06-01 |
Start Page: | 189 |
End Page: | 190 |
Language: | English |
DOI: | 10.1007/bf00306753 |
PUBMED: | 3459595 |
PROVIDER: | scopus |
DOI/URL: | |
Notes: | Article -- Export Date: 18 August 2021 -- Source: Scopus |